GENE ONLINE|News &
Opinion
Blog

2021-07-19| Asia-Pacific

CYTENA Launches the Next-Generation Microbioreactor to Revolutionize Cell Culture

by Tyler Chen
Share To

CYTENA Bioprocess Solutions, a CELLINK company, launches S.NEST, a high throughput microbioreactor with a monitoring system that maximizes cell growth, reduces workflow time, and turns data into valuable insights.

Cell culture plays a critical role in drug discovery, selection, and biologics manufacturing. CYTENA emphasized that “S.NEST revolutionizes the way to do cell cultures with its unique technology to increase efficiency and productivity for biologics production, drug screening, and functional genomics studies.”

With the patented reciprocating mixing technology, S.NEST enables cells to grow in suspension cultures with optimal growth space and oxygen supply, releasing the lab from weeks of work for cell upscaling and expansion. 

Its incubation chambers have individual environmental settings and are compatible with four 96-well or 24-well culture plates, demonstrating high cell cultivation. What’s more, the camera module in the microbioreactor provides real-time pH and dissolved oxygen monitoring during cell growth. Besides, the software embedded in the system is able to transform monitored data into research insights, maximizing efficiency and value.

S.NEST™ microbioreactor

The next-generation microbioreactor is an important innovation for cell line development, and it certainly has huge potential in cell culture research. The bioreactor has been testified by worldwide users that it can increase cell growth, delivering better results. In addition, with the real-time monitoring system, S.NEST becomes the next-generation microbioreactor that provides valuable insights to boost cell line development. From now on, S.NEST will continue to upgrade and provide laboratories with highly efficient cell culture breakthroughs.

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
CYTENA BPS and Leadgene Bio to Level Up Taiwan’s Protein Drugs Production
2022-06-05
CYTENA Bioprocess Solutions Closes $5M Funding to Develop Automatic High-throughput Screening Platform for Pharmaceuticals
2021-10-05
Cytena Bioprocess Solutions Closes Pre-A series Funding, Accelerates Development in Microbioreactors
2020-12-29
LATEST
Accelerated Bio and Pluristyx Generate Clinical-Grade Induced Pluripotent Stem Cells from Reprogrammed Human Trophoblast Stem Cells
2024-07-12
Novo Nordisk and PT Bio Farma Agree to Enhance Insulin Production for Diabetes Patients in Indonesia
2024-07-12
Alzheimer’s Drug LEQEMBI Approved for Treatment in Hong Kong
2024-07-12
Foreseen Biotech Strikes $1.03B Deal with Ipsen for First-in-Class ADC
2024-07-12
Synthetic Biology’s Innovator Dr. John Cumbers – Addressing Inefficiencies in Biopharma and Economic Sustainability
2024-07-11
Delivering Affordable Biologic Medicines Worldwide: An Interview with Tanvex Chairman and CEO, Henry Chen
2024-07-11
Roche Secures CE Mark for AI-Powered Glucose Monitoring Solution, Enhancing Diabetes Care with Predictive Insights
2024-07-11
EVENT
Scroll to Top